STOCK TITAN

[SCHEDULE 13G] Tharimmune, Inc. Passive Investment Disclosure (>5%)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 3,252,033 shares of Tharimmune, Inc. common stock, representing 8.92% of the class as of 12/31/2025.

ARK has sole power to vote and dispose of these 3,252,033 shares. Catherine Wood is reported with shared voting and dispositive power over the same shares. The securities are stated to be acquired and held in the ordinary course of business, not for changing or influencing control of Tharimmune.

Positive

  • None.

Negative

  • None.

Insights

ARK and Catherine Wood report a passive 8.92% stake in Tharimmune.

ARK Investment Management LLC and Catherine D. Wood disclose beneficial ownership of 3,252,033 Tharimmune common shares, or 8.92% of the class as of 12/31/2025. This crosses the 5% threshold that requires a Schedule 13G filing.

ARK holds sole voting and dispositive power over the shares, while Catherine Wood has shared voting and dispositive power, reflecting her control role at ARK. The certification states the position was acquired and is held in the ordinary course of business, and not to change or influence control of Tharimmune.

The filing characterizes this as a passive investment rather than an activist position. Future ownership reports and company filings may provide additional context on any changes in this stake or related governance developments.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



ARK Investment Management LLC
Signature:/s/ Kellen Carter
Name/Title:Kellen Carter, Chief Compliance Officer
Date:02/03/2026
Catherine D. Wood
Signature:/s/ Catherine D. Wood
Name/Title:Catherine D. Wood, Chief Executive Officer, Chief Investment Officer
Date:02/03/2026
Tharimmune Inc

NASDAQ:THAR

THAR Rankings

THAR Latest News

THAR Latest SEC Filings

THAR Stock Data

186.98M
53.96M
17.13%
1.5%
12.08%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER